Budget Cuts NIH Grants Again

WASHINGTON—The administration has proposed that the National Institutes of Health fund 700 fewer new and competing research grants this year as part of a plan to reduce the overall NIH budget in fiscal 1988. But it is unlikely that researchers will feel the pinch anytime soon. The proposal is part of a request to Congress to transfer $334 million already appropriated for this fiscal year. The present budget of $6.18 billion would drop by a corresponding amount, and the budget for next year

Written byRon Cowen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The proposal is part of a request to Congress to transfer $334 million already appropriated for this fiscal year. The present budget of $6.18 billion would drop by a corresponding amount, and the budget for next year would remain nearly constant, at $5.87 billion. The number of new and competing grants would drop from 6,354 to 5,654, and the total number of grants, including renewals, would fall from 19,811 to 19,111.

At the same time, the budget proposes $534 million for basic research, clinical and laboratory work and public education on AIDS. A 28 percent increase from the $416 million allocated this year, the funds would be divided chiefly among NIH ($334 million), the Centers for Disease Control ($112 million), the Alcohol, Drug Abuse and Mental Health Administration ($54 million), the Food and Drug Administration ($16 million), and the Health Resources and Services Administration ($6.6 million).

The proposal results in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies